10 Year Financial Data of Cantel Medical Corporation (CMN)

34.12 (1y: +52%)

Market Cap	926.1 M	P/E(ttm)	24.50
Enterprise Value	1.01 B	P/B	3.38

CMN- NYSE (USA)
Cantel Medical Corporation

Currently 4.5/5

Business Predictability Rank: 4.5-Star
Back Testing Results:
Average gain of all 4.5-Star stocks: 10.6% per year.
% of Stocks that are in still loss if held for 10yrs: 10%.
Read more:
What is Predictability Rank?
Performances of real portfolio
Top Ranked Predictable Companies

$34.12

1 Severe Warning Sign 3 Medium Warning Signs 3 Good Signs

Bookmark

Annual Rates (per share)	10 yrs*	5 yrs*	12 months*
Revenue Growth (%)	9	9.3	9
EBITDA Growth (%)	10.7	17.1	42.1
Free Cash Flow Growth (%)	11	22.5	37.5
Book Value Growth (%)	13.4	10.6	14.4

*12-month growth rate is calculated with the per share revenue (EBITDA, FCF, earnings) of the last 12 months over the per share revenue (EBITDA, FCF, earnings) over the previous 12 months. 5-year and 10-year growth rates are calculated with least-square regression based on the 5-year and 10-year numbers.

Trendline:

Export:

Print This Table Print

See this page for the explanation of the data and charts * All numbers are in millions except for per share data

Per Share Data	Annuals											Quarterly
Fiscal Period	Jul03	Jul04	Jul05	Jul06	Jul07	Jul08	Jul09	Jul10	Jul11	Jul12	TTM	Jan12	Apr12	Jul12	Oct12	Jan13

Revenue per Share ($)	5.81	7.45	8.15	7.89	8.99	10.15	10.52	10.76	12.55	14.48	14.94	3.65	3.63	3.68	3.70	3.93
EBITDA per Share	0.79	1.03	1.29	1.06	1.13	1.21	1.57	1.73	1.71	2.55	2.87	0.64	0.66	0.68	0.74	0.79
Free Cashflow per Share	0.48	0.77	0.88	0.66	0.02	0.55	1.08	0.92	0.87	1.69	1.65	0.41	0.44	0.60	0.30	0.31
Earnings per Share ($)	0.36	0.47	0.64	0.97	0.35	0.35	0.63	0.79	0.79	1.15	1.39	0.27	0.30	0.36	0.35	0.38
Dividends Per Share	--	--	--	--	--	--	--	0.07	0.08	0.09	0.10	0.05	--	0.05	--	0.06
Book Value per Share	3.15	3.79	4.48	5.78	6.36	6.87	7.57	8.23	9.15	10.34	11.02	9.63	9.94	10.29	10.58	11.02
Month End Stock Price	6.00	11.44	11.67	9.59	9.65	6.22	10.32	10.59	16.62	26.12	31.41	21.05	23.48	26.12	26.01	31.41
Ratios	Annuals											Quarterly
Fiscal Period	Jul03	Jul04	Jul05	Jul06	Jul07	Jul08	Jul09	Jul10	Jul11	Jul12	Latest Q.	Jan12	Apr12	Jul12	Oct12	Jan13

Return on Equity %	11.30	12.30	14.30	16.80	5.40	5.20	8.30	9.50	8.70	11.40	14.00	11.20	12.40	14.00	13.60	14.00
Return on Assets %	7.20	7.30	9.40	9.90	3.20	3.10	5.60	7.10	6.40	7.20	8.80	6.80	7.60	8.80	8.80	8.80
Return on Capital - Joel Greenblatt %	26.40	34.60	46.70	27.60	24.20	24.50	37.90	42.80	37.30	51.30	58.40	51.20	52.80	56.80	62.00	58.40
Debt to Equity	0.30	0.29	0.15	0.27	0.37	0.35	0.23	0.10	0.10	0.33	0.36	0.42	0.38	0.33	0.28	0.36

Gross Margin %	37.30	36.70	38.60	36.00	36.10	35.10	38.30	40.50	38.20	42.50	42.40	42.00	43.80	43.30	43.90	42.40
Operating Margin %	10.50	11.10	13.30	8.00	7.70	7.20	10.60	11.90	9.70	13.50	15.90	13.50	14.20	14.60	16.00	15.90
Net Margin %	6.10	6.30	7.90	12.30	3.90	3.50	6.00	7.30	6.40	8.10	9.80	7.50	8.40	9.80	9.60	9.80

Days Sales Outstanding	66.10	63.00	63.30	45.00	50.70	44.40	42.70	42.50	52.30	47.10	45.30	42.90	43.30	45.90	44.50	45.30
Days Inventory	80.60	76.20	66.70	71.10	71.20	71.80	66.40	77.50	73.50	76.80	72.30	75.40	79.20	76.10	77.40	72.30
Inventory Turnover	4.50	4.80	5.50	5.10	5.10	5.10	5.50	4.70	5.00	4.80	1.30	1.20	1.10	1.20	1.20	1.30

Debt to Revenue	0.16	0.15	0.08	0.20	0.26	0.23	0.17	0.08	0.08	0.23	1.01	1.11	1.03	0.91	0.80	1.01
COGS to Revenue	0.63	0.63	0.61	0.64	0.64	0.65	0.62	0.59	0.62	0.58	0.58	0.58	0.56	0.57	0.56	0.58
Inventory to Revenue	0.14	0.13	0.11	0.13	0.13	0.13	0.11	0.13	0.13	0.12	0.46	0.48	0.49	0.47	0.48	0.46
Interest Exp. to Revenue %	-1.03	-0.97	-0.54	-1.77	-1.25	-1.65	-0.96	-0.41	-0.27	-0.94	-0.73	-1.00	-0.91	-0.80	-0.64	-0.73

Asset Turnover	1.18	1.16	1.20	0.81	0.83	0.89	0.94	0.98	1.00	0.89	0.23	0.23	0.23	0.23	0.23	0.23
Buyback Ratio	-5.30	-30.00	-17.60	-11.00	-43.00	-13.20	--	--	--	--	--	--	--	--	--	--
Dividend Payout Ratio	--	--	--	--	--	--	--	0.09	0.10	0.08	0.14	0.17	--	0.13	--	0.14
Income Statement	Annuals (USD $) View: $ %											Quarterly
Fiscal Period	Jul03	Jul04	Jul05	Jul06	Jul07	Jul08	Jul09	Jul10	Jul11	Jul12	TTM	Jan12	Apr12	Jul12	Oct12	Jan13

Revenue	129	170	197	192	219	249	260	274	322	386	402	97.30	97.24	98.69	99.68	106
Cost of Goods Sold	81.06	108	121	123	140	162	161	163	199	222	228	56.48	54.62	55.92	55.95	61.21
Gross Profit	48.19	62.46	76.24	69.22	79.01	87.63	99.48	111	123	164	174	40.82	42.62	42.78	43.73	45.15

Selling, General, &Admin. Expense	30.13	39.35	45.95	48.76	57.33	65.65	67.40	73.14	84.80	103	104	25.36	26.63	25.77	25.46	26.11
Research &Development	4.53	4.21	4.10	5.12	4.85	4.01	4.63	5.17	6.65	9.25	9.29	2.30	2.22	2.59	2.29	2.18
Earnings Before DDA	17.57	23.59	31.31	25.88	27.43	29.70	38.82	44.10	43.78	68.05	77.40	17.16	17.79	18.36	20.00	21.25

Depreciation, Depletion and Amortization	4.03	4.69	5.12	10.54	10.59	11.73	11.37	11.44	12.45	15.93	16.38	4.00	4.01	3.95	4.03	4.39

Operating Income	13.54	18.90	26.19	15.34	16.84	17.97	27.45	32.67	31.34	52.12	61.02	13.16	13.77	14.41	15.97	16.86
Interest Income/Expense	-1.33	-1.65	-1.06	-3.39	-2.74	-4.12	-2.50	-1.11	-0.87	-3.65	-3.08	-0.98	-0.88	-0.79	-0.63	-0.78
Net Income	7.91	10.65	15.51	23.70	8.45	8.69	15.57	19.94	20.43	31.34	37.85	7.29	8.17	9.65	9.58	10.45

Earnings per Share ($)	0.36	0.47	0.64	0.97	0.35	0.35	0.63	0.79	0.79	1.15	1.39	0.27	0.30	0.36	0.35	0.38
Total Shares Outstanding	22.25	22.83	24.23	24.35	24.36	24.56	24.72	25.45	25.62	26.68	27.04	26.65	26.80	26.83	26.91	27.04
Balance Sheet	Annuals (USD $) View: $ %											Quarterly
Fiscal Period	Jul03	Jul04	Jul05	Jul06	Jul07	Jul08	Jul09	Jul10	Jul11	Jul12	Latest Q.	Jan12	Apr12	Jul12	Oct12	Jan13

Cash and cash equivalents	17.02	17.86	33.34	29.90	15.86	18.32	23.37	22.61	18.41	30.19	26.83	21.69	25.03	30.19	27.87	26.83
Accounts Receivable	23.42	29.32	34.25	23.72	30.44	30.32	30.45	31.87	46.12	49.83	52.96	45.90	46.30	49.83	48.77	52.96
Inventory	17.90	22.45	22.13	23.94	27.32	31.80	29.20	34.62	40.06	46.76	48.66	46.82	47.52	46.76	47.59	48.66
Other Current Assets	3.59	4.22	3.95	4.89	3.11	4.13	5.89	5.63	6.73	7.12	9.60	8.17	7.81	7.12	8.98	9.60
Total Current Assets	61.93	73.86	93.67	82.45	76.73	84.56	88.91	94.73	111	134	138	123	127	134	133	138

Property, Plant and Equipment	21.74	22.72	22.66	38.10	38.58	37.92	35.97	35.24	34.46	43.02	45.78	43.72	43.26	43.02	42.40	45.78
Intangible Assets	23.40	47.23	46.66	116	147	155	152	150	174	255	285	259	257	255	253	285
Other Long Term Assets	2.75	2.56	1.35	1.89	1.68	1.50	0.96	1.19	1.70	2.93	2.97	3.07	3.06	2.93	3.06	2.97
Total Assets	110	146	164	238	264	279	278	281	321	435	472	429	430	435	431	472

Accounts Payable	12.28	24.13	16.95	15.70	18.56	16.53	26.29	26.75	36.69	37.03	31.87	34.67	32.97	37.03	35.38	31.87
Current Portion of Long-Term Debt	3.00	3.00	15.75	4.00	6.00	8.00	10.00	10.00	--	10.00	10.00	10.00	10.00	10.00	10.00	10.00
Other Current Liabilities	3.00	--	9.95	19.40	11.42	14.39	2.82	4.23	6.72	8.11	9.52	6.91	7.72	8.11	9.24	9.52
Total Current Liabilities	18.29	27.13	42.65	39.10	35.97	38.92	39.11	40.98	43.41	55.14	51.39	51.57	50.69	55.14	54.62	51.39

Long-Term Debt	17.75	22.00	--	34.00	51.00	50.30	33.30	11.00	24.00	80.00	97.00	98.00	90.50	80.00	70.00	97.00
Other Long-Term Liabilities	3.59	10.73	13.06	24.33	21.63	21.26	18.34	19.28	19.72	23.74	25.47	22.46	22.75	23.74	22.26	25.47
Total Liabilities	39.63	59.86	55.71	97.42	109	110	90.76	71.26	87.13	159	174	172	164	159	147	174

Common Stock	0.96	1.00	1.55	1.62	1.71	1.75	1.79	1.83	1.92	3.00	3.00	2.99	3.00	3.00	3.00	3.00
Retained Earnings	19.54	30.19	45.70	69.40	77.84	86.53	102	120	139	168	186	151	159	168	176	186
Additional Paid-In Capital	49.63	53.82	57.49	69.17	76.84	81.48	87.17	94.71	111	127	133	122	125	127	129	133
Treasury Stock	-1.20	-1.65	-1.73	-6.09	-9.82	-11.34	-12.23	-15.54	-26.34	-30.12	-31.97	-27.88	-28.91	-30.12	-31.55	-31.97
Total Equity	70.18	86.51	109	141	155	169	187	209	234	276	298	257	266	276	285	298
Cashflow Statement	Annuals (USD $) View: $ %											Quarterly
Fiscal Period	Jul03	Jul04	Jul05	Jul06	Jul07	Jul08	Jul09	Jul10	Jul11	Jul12	TTM	Jan12	Apr12	Jul12	Oct12	Jan13

Net Income	7.91	10.65	15.51	23.70	8.45	8.69	15.57	19.94	20.43	31.34	37.85	7.29	8.17	9.65	9.58	10.45
Depreciation, Depletion and Amortization	4.03	4.69	5.12	10.54	10.59	11.73	11.37	11.44	12.45	15.93	16.38	4.00	4.01	3.95	4.03	4.39
Cash Flow from Others	-0.11	4.20	4.15	-12.18	-13.07	-1.87	4.05	-2.35	-4.67	3.32	-4.44	0.85	0.83	4.13	-4.23	-5.16
Cash Flow from Operations	11.83	19.54	24.77	22.06	5.97	18.56	30.99	29.03	28.20	50.58	49.79	12.14	13.02	17.73	9.37	9.68

Investment for Property, Plant & Equipement	-1.10	-1.92	-3.35	-6.07	-5.53	-4.98	-4.22	-5.61	-5.84	-5.50	-5.50	-1.26	-1.31	-1.64	-1.17	-1.38
Cash Flow from Acquisitions	--	-24.73	--	-71.13	-36.07	-13.55	-5.04	-2.13	-29.65	-97.67	-38.14	0.12	-1.37	--	--	-36.77
Cash Flow from Investing	-1.60	-26.70	-3.63	-45.95	-41.54	-18.47	-11.45	-8.24	-35.72	-103	-43.67	-1.10	-2.87	-1.39	-1.24	-38.17

Net Issuance of Stock	0.42	3.20	2.73	-1.64	1.38	0.30	-0.40	-0.43	-1.29	-1.90	-3.05	-0.43	-0.78	-0.40	-1.58	-0.29
Net Issuance of Debt	-7.75	4.25	-9.25	20.98	19.00	1.30	-15.00	-22.30	3.00	64.59	-1.00	-8.51	-7.50	-10.50	-10.00	27.00
Cash Flow for Dividends	--	--	--	--	--	--	--	-1.68	-2.06	-2.52	-2.76	-1.26	--	-1.27	--	-1.49
Other Financing	0.00	-0.39	--	0.79	0.71	0.29	1.58	2.56	3.33	4.34	5.78	1.23	1.43	1.08	1.09	2.19
Cash Flow from Financing	-7.33	7.05	-6.52	20.13	21.08	1.88	-13.82	-21.85	2.98	64.50	-1.03	-8.97	-6.85	-11.09	-10.49	27.40

Net Change in Cash	4.45	0.84	15.47	-3.44	-14.04	2.46	5.05	-0.76	-4.20	11.78	5.14	2.04	3.34	5.16	-2.32	-1.04

Free Cash Flow	10.73	17.63	21.42	15.99	0.44	13.57	26.78	23.43	22.36	45.08	44.29	10.88	11.70	16.09	8.20	8.30
Valuation Ratios (Daily)	Annuals											Quarterly
Fiscal Period	Jul03	Jul04	Jul05	Jul06	Jul07	Jul08	Jul09	Jul10	Jul11	Jul12	Latest Q.	Jan12	Apr12	Jul12	Oct12	Jan13

PE Ratio(ttm)
Price to Tangible Book
Price-to-Free-Cash-Flow ratio
PS Ratio
EV-to-Revenue
EV-to-EBITDA
EV-to-EBIT
Earnings Yield (Joel Greenblatt)
Forward Rate of Return
Shiller PE Ratio
Valuation and Quality	Annuals											Quarterly
Fiscal Period	Jul03	Jul04	Jul05	Jul06	Jul07	Jul08	Jul09	Jul10	Jul11	Jul12	Latest Q.	Jan12	Apr12	Jul12	Oct12	Jan13

Market Cap
Enterprise Value
Month End Stock Price
Net Cash (per share)
Net Current Asset Value (per share)
DCF (per share)
Median PS (per share)
Peter Lynch Fair Value (per share)
Graham Number (per share)
Altman Z-Score
Piotroski F-Score
Beneish M-Score

Switch to Another Stock:

CMN Quarterly/Annuals Reports

CMN: 10-Q - CANTEL MEDICAL CORP (0000019446) (Filer): (10-Q) - 2012-12-10
CMN: 10-Q - CANTEL MEDICAL CORP (0000019446) (Filer): (10-Q) - 2012-06-11
CMN: 10-Q - CANTEL MEDICAL CORP (0000019446) (Filer): (10-Q) - 2012-03-12
CMN: 10-Q - CANTEL MEDICAL CORP (0000019446) (Filer): (10-Q) - 2011-12-12
CMN: 10-K - CANTEL MEDICAL CORP (0000019446) (Filer): (10-K) - 2011-10-14

GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names

Home About Jobs Advertise Site Map Term of Use Privacy Policy RSS Email Alerts Affiliate Program FAQ Contact Us
Disclaimers: GuruFocus.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The gurus may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.

FocusBar

Home

Premium Membership

Value Screens

Model Portfolios

Guru Stocks

Market Valuation

By Country

Articles

Submit Articles

CMN Quarterly/Annuals Reports